Alzheimer’s monoclonal antibodies fail to deliver meaningful results
The Amyloid Paradox: Clearing Plaques vs. Restoring Memory For years, the scientific community focused on the “amyloid hypothesis”—the idea that removing amyloid-beta (Aβ) plaques from the brain would stop or reverse Alzheimer’s disease. Recent data shows a complex reality: while monoclonal antibodies (mAbs) are highly effective at clearing these plaques, the clinical results are a … Read more